NEW YORK, NY – October 5, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced a collaboration with Ariana Pharma (Cambridge, MA and Paris, France) to use Ariana’s proprietary KEM® (Knowledge, Extraction, Management) patient stratification technology to potentially accelerate ANAVEX 2-73’s Phase 2/3 Alzheimer’s clinical development timelines. KEM® is a comprehensive and FDA-tested clinical data analysis system that enables full exploitation of complex datasets including of smaller numbers of patients. (more…)
Ariana’s advanced data analytics, using its KEM® decision support platform, will help ValiSeek boost success outlook. Ariana® Pharma, a leading digital health Company focused on developing advanced personalized therapeutic decision support systems and a provider of decision support tools and services to accelerate drug development, announces today that it has won a significant contract of a fee-for-service collaboration with ValiSeek, a joint venture of ValiRx Plc (AIM: VAL). (more…)
Ariana is pleased to announce that the company has joined the Healthcare Data Institute.
The Healthcare Data Institute is the first international think tank dedicated to Big Data in the health sector. An Orange Healthcare initiative, the Healthcare Data Institute was launched in partnership with other companies representative of the Big Data health ecosystem: government and regulatory agencies, pharmaceutical companies, leading figures from the medical world, start-ups and insurance companies.
(more…)
Dr Afshar will moderate a panel on End-to-End Companion Diagnostics Development at 2nd Annual Personalised Medicines and Cancer Biomarkers 2016 in London on 12-13 October 2016.
Dr Kuras (CTO) shares her expertise at this leading Biomarkers International Conference and will deliver a presentation on "Transforming Big Data towards Therapeutic Decision Systems"
Interview with Mohammad Afshar – CEO, Ariana Pharma, France, 12 July 2016
The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Ariana team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.
Ariana hosted their regular Science Day this week - a 1-day symposium in Paris on advances in machine learning and artificial intelligence, chaired by Dr Jean Sallantin, Director of Research at the CNRS LIRMM (Laboratoire d’Informatique, de Robotique et de Micro-électronique de Montpellier) and Scientific Advisor to Ariana. (more…)
